Table 1. Variables of renal function.
Reperfusion period (h) | SO-P | SO-T3 | IR-P | IR-T3 | |
Plasma Creatinine (mg/dl) | 4 | 0,28±0,05 | 0,27±0,03 | 0,77±0,21** | 1,03±0,33† † |
24 | 0,25±0,05 | 0,22±0,04 | 0,45±0,16** | 0,62±0,21† † | |
48 | 0,27±0,03 | 0,26±0,02 | 0,52±0,06** | 0,28±0,04 ‡ ‡ | |
Plasma Urea (mg/dl) | 4 | 27,9±4,6 | 31,1±5,6 | 49,4±4,7** | 61,7±7,8† † |
24 | 24,1±4,8 | 23,1±3,3 | 43,2±12,7** | 68,1±14,3† † | |
48 | 28,2±3,4 | 29,6±3,3 | 42,9±2,2** | 35,4±3,6† † ‡ | |
Proteinuria (mg/ml/100g body wt) | 4 | 0,43±0,11 | 0,47±0,11 | 5,41±0,38** | 3,71±0,44† † ‡ |
24 | 0,47±0,09 | 0,38±0,08 | 4,22±0,75** | 1,81±0,44† † ‡ | |
48 | 0,36±0,1 | 0,32±0,04 | 2,79±0,26** | 1,22±0,13† † ‡ | |
Creatinine Clearence (ml/min/ 100g body wt) | 4 | 0,62±0,14 | 0,54±0,17 | 0,35±0,31** | 0.15±0,13† † |
24 | 0,78±0,17 | 0,68±0,14 | 0,39±0,08** | 0,35±0,09† † | |
48 | 0,58±0,08 | 0,58±0,06 | 0,22±0,09** | 0,57±0,15 ‡ ‡ |
SO-P = sham-operated-placebo; SO-T3 = sham-operated, T3-treated (100 μg/kg); IR-P = ischemia-reperfusion, placebo-treated; IR-T3 = ischemia-reperfusion, T3-treated. Data are means ± SEM, n = 10 each group. * p<0.01, ** p<0.001 compared with the SO-P group. † p<0.01, † † p<0.001 compared with the SO-T3 group. ‡ p<0.01, ‡ ‡ p<0.001 compared with the IR-P group.